Tang-Capital-Management

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
202
Total Value
1807581363
Accession Number
0001214659-25-007882
Form Type
13F-HR
Manager Name
Tang-Capital-Management
Data Enrichment
98% identified
198 identified4 unidentified

Holdings

202 positions • $1.8B total value
Manager:
Search and click to pin securities to the top
Page 2 of 11
ANI PHARMACEUTICALS INC
Shares:317.5K
Value:$21.3M
% of Portfolio:1.2% ($21.3M/$1.8B)
Relay Therapeutics, Inc.
Shares:8.1M
Value:$21.1M
% of Portfolio:1.2% ($21.1M/$1.8B)
Compass Therapeutics, Inc.
Shares:11.1M
Value:$21.0M
% of Portfolio:1.2% ($21.0M/$1.8B)
ADMA BIOLOGICS, INC.
Shares:1.1M
Value:$20.8M
% of Portfolio:1.2% ($20.8M/$1.8B)
LENZ Therapeutics, Inc.
Shares:766.9K
Value:$19.7M
% of Portfolio:1.1% ($19.7M/$1.8B)
ASTRAZENECA PLC
Shares:250.0K
Value:$18.4M
% of Portfolio:1.0% ($18.4M/$1.8B)
Liquidia Corp
Shares:1.2M
Value:$17.7M
% of Portfolio:1.0% ($17.7M/$1.8B)
NEUROCRINE BIOSCIENCES INC
Shares:150.0K
Value:$16.6M
% of Portfolio:0.9% ($16.6M/$1.8B)
AVADEL PHARMACEUTICALS PLC
Shares:2.1M
Value:$16.4M
% of Portfolio:0.9% ($16.4M/$1.8B)
iTeos Therapeutics, Inc.
Shares:2.7M
Value:$16.1M
% of Portfolio:0.9% ($16.1M/$1.8B)
Meta Platforms, Inc.
Shares:27.6K
Value:$15.9M
% of Portfolio:0.9% ($15.9M/$1.8B)
GSK plc
Shares:400.0K
Value:$15.5M
% of Portfolio:0.9% ($15.5M/$1.8B)
NVIDIA CORP
Shares:142.6K
Value:$15.5M
% of Portfolio:0.9% ($15.5M/$1.8B)
Shares:270.0K
Value:$15.0M
% of Portfolio:0.8% ($15.0M/$1.8B)
Atea Pharmaceuticals, Inc.
Shares:4.8M
Value:$14.4M
% of Portfolio:0.8% ($14.4M/$1.8B)
Altimmune, Inc.
Shares:2.8M
Value:$13.8M
% of Portfolio:0.8% ($13.8M/$1.8B)
Zymeworks Inc.
Shares:1.1M
Value:$13.1M
% of Portfolio:0.7% ($13.1M/$1.8B)
Nkarta, Inc.
Shares:7.1M
Value:$13.0M
% of Portfolio:0.7% ($13.0M/$1.8B)
CARGO Therapeutics, Inc.
Shares:3.1M
Value:$12.5M
% of Portfolio:0.7% ($12.5M/$1.8B)
CYBIN INC.
Shares:1.8M
Value:$11.6M
% of Portfolio:0.6% ($11.6M/$1.8B)